These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35699875)

  • 41. [Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)].
    Chen YC; Hsiao CT; Soong BW; Lee YC
    Acta Neurol Taiwan; 2014 Jun; 23(2):64-74. PubMed ID: 26035923
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Lee YC; Chung CP; Chang MH; Wang SJ; Liao YC
    Neurology; 2020 Jan; 94(1):e87-e96. PubMed ID: 31792094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cysteine-sparing CADASIL mutations in NOTCH3 show proaggregatory properties in vitro.
    Wollenweber FA; Hanecker P; Bayer-Karpinska A; Malik R; Bäzner H; Moreton F; Muir KW; Müller S; Giese A; Opherk C; Dichgans M; Haffner C; Duering M
    Stroke; 2015 Mar; 46(3):786-92. PubMed ID: 25604251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracerebral Hemorrhage in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prevalence, Clinical and Neuroimaging Features and Risk Factors.
    Liao YC; Hu YC; Chung CP; Wang YF; Guo YC; Tsai YS; Lee YC
    Stroke; 2021 Mar; 52(3):985-993. PubMed ID: 33535780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects.
    Di Donato I; Bianchi S; De Stefano N; Dichgans M; Dotti MT; Duering M; Jouvent E; Korczyn AD; Lesnik-Oberstein SA; Malandrini A; Markus HS; Pantoni L; Penco S; Rufa A; Sinanović O; Stojanov D; Federico A
    BMC Med; 2017 Feb; 15(1):41. PubMed ID: 28231783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CODAS syndrome is associated with mutations of LONP1, encoding mitochondrial AAA+ Lon protease.
    Strauss KA; Jinks RN; Puffenberger EG; Venkatesh S; Singh K; Cheng I; Mikita N; Thilagavathi J; Lee J; Sarafianos S; Benkert A; Koehler A; Zhu A; Trovillion V; McGlincy M; Morlet T; Deardorff M; Innes AM; Prasad C; Chudley AE; Lee IN; Suzuki CK
    Am J Hum Genet; 2015 Jan; 96(1):121-35. PubMed ID: 25574826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease.
    Verdura E; Hervé D; Scharrer E; Amador Mdel M; Guyant-Maréchal L; Philippi A; Corlobé A; Bergametti F; Gazal S; Prieto-Morin C; Beaufort N; Le Bail B; Viakhireva I; Dichgans M; Chabriat H; Haffner C; Tournier-Lasserve E
    Brain; 2015 Aug; 138(Pt 8):2347-58. PubMed ID: 26063658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unique presentation of LHON/MELAS overlap syndrome caused by m.13046T>C in MTND5.
    Kolarova H; Liskova P; Tesarova M; Kucerova Vidrova V; Forgac M; Zamecnik J; Hansikova H; Honzik T
    Ophthalmic Genet; 2016 Dec; 37(4):419-423. PubMed ID: 26894521
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Hu Y; Sun Q; Zhou Y; Yi F; Tang H; Yao L; Tian Y; Xie N; Luo M; Wang Z; Liao X; Xu H; Zhou L
    Front Genet; 2021; 12():705284. PubMed ID: 34335700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NOTCH3 mutations in a cohort of Portuguese patients within CADASIL spectrum phenotype.
    Almeida MR; Elias I; Fernandes C; Machado R; Galego O; Santo G
    Neurogenetics; 2022 Jan; 23(1):1-9. PubMed ID: 34851492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of the mitochondrial protein quality control system and actin cytoskeletal alterations in cells harbouring the MELAS mitochondrial DNA mutation.
    Felk S; Ohrt S; Kussmaul L; Storch A; Gillardon F
    J Neurol Sci; 2010 Aug; 295(1-2):46-52. PubMed ID: 20570288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted next generation sequencing identifies novel NOTCH3 gene mutations in CADASIL diagnostics patients.
    Maksemous N; Smith RA; Haupt LM; Griffiths LR
    Hum Genomics; 2016 Nov; 10(1):38. PubMed ID: 27881154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathy.
    Pippucci T; Maresca A; Magini P; Cenacchi G; Donadio V; Palombo F; Papa V; Incensi A; Gasparre G; Valentino ML; Preziuso C; Pisano A; Ragno M; Liguori R; Giordano C; Tonon C; Lodi R; Parmeggiani A; Carelli V; Seri M
    EMBO Mol Med; 2015 Jun; 7(6):848-58. PubMed ID: 25870235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RVCL-S and CADASIL display distinct impaired vascular function.
    de Boer I; Stam AH; Buntinx L; Zielman R; van der Steen I; van den Maagdenberg AMJM; de Koning EJP; Ferrari MD; de Hoon JN; Terwindt GM
    Neurology; 2018 Sep; 91(10):e956-e963. PubMed ID: 30076273
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adult-onset Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke (MELAS)-like Encephalopathy Diagnosed Based on the Complete Sequencing of Mitochondrial DNA Extracted from Biopsied Muscle without any Myopathic Changes.
    Mukai M; Nagata E; Mizuma A; Yamano M; Sugaya K; Nishino I; Goto YI; Takizawa S
    Intern Med; 2017; 56(1):95-99. PubMed ID: 28050007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke.
    Kilarski LL; Rutten-Jacobs LC; Bevan S; Baker R; Hassan A; Hughes DA; Markus HS;
    PLoS One; 2015; 10(8):e0136352. PubMed ID: 26305465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease.
    Yamamoto Y; Kojima K; Taura D; Sone M; Washida K; Egawa N; Kondo T; Minakawa EN; Tsukita K; Enami T; Tomimoto H; Mizuno T; Kalaria RN; Inagaki N; Takahashi R; Harada-Shiba M; Ihara M; Inoue H
    Mol Brain; 2020 Mar; 13(1):38. PubMed ID: 32188464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
    Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
    Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL.
    Opherk C; Gonik M; Duering M; Malik R; Jouvent E; Hervé D; Adib-Samii P; Bevan S; Pianese L; Silvestri S; Dotti MT; De Stefano N; Liem M; Boon EM; Pescini F; Pachai C; Bracoud L; Müller-Myhsok B; Meitinger T; Rost N; Pantoni L; Lesnik Oberstein S; Federico A; Ragno M; Markus HS; Tournier-Lasserve E; Rosand J; Chabriat H; Dichgans M
    Stroke; 2014 Apr; 45(4):968-72. PubMed ID: 24578207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain.
    Yamamoto Y; Craggs L; Baumann M; Kalimo H; Kalaria RN
    Neuropathol Appl Neurobiol; 2011 Feb; 37(1):94-113. PubMed ID: 21062344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.